National Health Investors Inc
NYSE:NHI
National Health Investors Inc
NYSE:NHI
Price:
66.51 USD
-0.2%
Market Closed
Updated:
May 18, 2024
National Health Investors Inc
Cost of Revenue
|
National Health Investors Inc
Cost of Revenue Peer Comparison
Comparables:
WELL
OHI
HR
VTR
DOC
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
National Health Investors Inc
NYSE:NHI
|
Cost of Revenue
-$51.1m
|
CAGR 3-Years
-74%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Welltower Inc
NYSE:WELL
|
Cost of Revenue
-$3.9B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-13%
|
|
|
Omega Healthcare Investors Inc
NYSE:OHI
|
Cost of Revenue
-$15.3m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
Healthcare Realty Trust Inc
NYSE:HR
|
Cost of Revenue
-$500.4m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-18%
|
|
|
Ventas Inc
NYSE:VTR
|
Cost of Revenue
-$2.6B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-9%
|
|
|
Physicians Realty Trust
NYSE:DOC
|
Cost of Revenue
-$880.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-11%
|
See Also
What is National Health Investors Inc's Cost of Revenue?
Cost of Revenue
-51.1m
USD
-51.1m
USD
Based on the financial report for Dec 31, 2023, National Health Investors Inc's Cost of Revenue amounts to -51.1m USD.
What is National Health Investors Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-74%
-74%
Over the last year, the Cost of Revenue growth was -34%. The average annual Cost of Revenue growth rates for National Health Investors Inc have been -74% over the past three years .
You don't have any saved screeners yet
